Pharmaceutical

Boies Schiller Flexner LLP Faces Legal Setback in Ongoing Pharmaceutical Counsel Dispute

by

Miami, Florida — A federal court has ruled against Boies Schiller Flexner LLP in a case involving former counsel to various pharmaceutical mass tort firms. The decision means that the law firm must remain part of a ongoing lawsuit, facing scrutiny alongside other defendants. The dispute centers on claims from several mass tort firms that seek compensation from their former attorneys. These firms have accused Boies Schiller Flexner LLP and others of negligence and misconduct that allegedly impacted their operations and relationships with clients. Court documents reveal that the plaintiffs argue that the actions taken … Read more

Federal Court Sends Pharmaceutical Lawsuit Back to State, Keeping Boies Schiller in Legal Spotlight

by

Miami, Florida — A federal judge has determined that Boies Schiller Flexner LLP remains implicated in a continuing legal battle involving pharmaceutical mass tort firms and their previous counsel. In a ruling issued Thursday, the judge remanded the case back to state court, affirming that the allegations against the law firm have sufficient merit to proceed. The lawsuit revolves around claims from various pharmaceutical tort firms, which allege that their former legal representation may have mishandled certain aspects of their cases. By sending the case back to state level jurisdiction, the judge has effectively allowed … Read more

Pharmaceutical Heir Files Lawsuit, Accusing Attorney of $10 Million Fraud in Legal Gift Dispute

by

BALTIMORE — Claudia Engelhorn, the heir of a prominent German pharmaceutical magnate, is embroiled in a legal dispute, alleging that her former attorney swindled her out of $10 million. Engelhorn claims that Erik Bolog falsely presented the payment as a gift for his legal services, with her previous law firm failing to intervene amidst the situation. The legal battles began when Engelhorn initiated litigation against Bolog and his former employer, Whiteford, Taylor & Preston. At the heart of the conflict is Bolog’s assertion that the payment was a voluntary gift meant to express gratitude for … Read more

Ohio AG Leads Charge in Major Class-Action Lawsuit Against Pharmaceutical Giant Over Hidden Cancer Risks in Popular Heartburn Medication

by

COLUMBUS, Ohio — Attorney General Dave Yost of Ohio is spearheading efforts to lead a class-action lawsuit that targets the pharmaceutical giant GSK, previously known as GlaxoSmithKline, over allegations of hiding cancer risks associated with its heartburn medication Zantac. The litigation focuses on purported investor losses and claims of misleading information regarding the drug’s safety. On Monday, Yost filed a motion proposing that the Ohio Public Employees Retirement System (OPERS) join forces with the Indiana Public Retirement System as co-lead plaintiffs in the lawsuit. This legal action follows reports that OPERS suffered a considerable financial … Read more